Figure 1
OS and RFS of patients with AML in CR1 randomized to ASCT or consolidation chemotherapy.

OS and RFS of patients with AML in CR1 randomized to ASCT or consolidation chemotherapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal